Principal Financial Group Inc Ani Pharmaceuticals Inc Transaction History

Principal Financial Group Inc

$172 Billion
Q4 2024

A detailed history of Principal Financial Group Inc transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 93,777 shares of ANIP stock, worth $5.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

93,777

Holding current value

$5.64 Million

% of portfolio

0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$53.35 - $61.74 $5 Million - $5.79 Million	93,777 New	93,777 $5.18 Million
Q3 2024 Oct 31, 2024	BUY	$54.33 - $65.72 $316,689 - $383,081	5,829 Added 6.93%	89,961 $5.37 Million
Q2 2024 Jul 29, 2024	SELL	$58.53 - $68.82 $208,776 - $245,480	-3,567 Reduced 4.07%	84,132 $5.36 Million
Q1 2024 Apr 29, 2024	BUY	$54.2 - $69.69 $359,129 - $461,765	6,626 Added 8.17%	87,699 $6.06 Million
Q4 2023 Feb 07, 2024	SELL	$48.72 - $65.43 $365,010 - $490,201	-7,492 Reduced 8.46%	81,073 $4.47 Million
Q3 2023 Nov 02, 2023	BUY	$50.28 - $64.61 $332,300 - $427,007	6,609 Added 8.06%	88,565 $5.14 Million
Q2 2023 Aug 07, 2023	BUY	$37.29 - $53.83 $198,569 - $286,644	5,325 Added 6.95%	81,956 $4.41 Million
Q1 2023 May 09, 2023	SELL	$37.61 - $45.72 $36,218 - $44,028	-963 Reduced 1.24%	76,631 $3.04 Million
Q4 2022 Feb 09, 2023	SELL	$31.9 - $41.95 $39,843 - $52,395	-1,249 Reduced 1.58%	77,594 $3.12 Million
Q3 2022 Nov 09, 2022	SELL	$29.83 - $38.01 $418,693 - $533,508	-14,036 Reduced 15.11%	78,843 $2.53 Million
Q2 2022 Aug 10, 2022	BUY	$23.09 - $33.46 $114,341 - $165,693	4,952 Added 5.63%	92,879 $2.76 Million
Q1 2022 May 09, 2022	BUY	$26.91 - $47.15 $271,710 - $476,073	10,097 Added 12.97%	87,927 $2.47 Million
Q4 2021 Feb 09, 2022	BUY	$32.97 - $56.85 $388,188 - $669,351	11,774 Added 17.82%	77,830 $3.59 Million
Q3 2021 Nov 09, 2021	SELL	$26.48 - $35.99 $68,583 - $93,214	-2,590 Reduced 3.77%	66,056 $2.17 Million
Q2 2021 Aug 10, 2021	SELL	$31.86 - $38.6 $194,728 - $235,923	-6,112 Reduced 8.18%	68,646 $2.41 Million
Q1 2021 May 10, 2021	BUY	$28.4 - $36.14 $17,238 - $21,936	607 Added 0.82%	74,758 $2.7 Million
Q4 2020 Feb 08, 2021	SELL	$23.69 - $31.47 $50,009 - $66,433	-2,111 Reduced 2.77%	74,151 $2.15 Million
Q3 2020 Nov 06, 2020	BUY	$26.38 - $33.1 $35,797 - $44,916	1,357 Added 1.81%	76,262 $2.15 Million
Q2 2020 Aug 05, 2020	SELL	$29.93 - $50.1 $174,072 - $291,381	-5,816 Reduced 7.21%	74,905 $2.42 Million
Q1 2020 May 12, 2020	SELL	$30.35 - $67.14 $87,256 - $193,027	-2,875 Reduced 3.44%	80,721 $3.29 Million
Q4 2019 Feb 05, 2020	BUY	$55.65 - $79.83 $339,687 - $487,282	6,104 Added 7.88%	83,596 $5.16 Million
Q3 2019 Nov 13, 2019	BUY	$64.7 - $85.39 $389,688 - $514,303	6,023 Added 8.43%	77,492 $5.65 Million
Q2 2019 Aug 12, 2019	BUY	$67.77 - $82.2 $325,770 - $395,135	4,807 Added 7.21%	71,469 $5.88 Million
Q1 2019 May 10, 2019	SELL	$45.83 - $70.54 $30,431 - $46,838	-664 Reduced 0.99%	66,662 $4.7 Million
Q4 2018 Feb 14, 2019	BUY	$41.17 - $56.44 $21,778 - $29,856	529 Added 0.79%	67,326 $3.03 Million
Q3 2018 Nov 14, 2018	SELL	$52.95 - $71.34 $206,663 - $278,440	-3,903 Reduced 5.52%	66,797 $3.78 Million
Q2 2018 Aug 13, 2018	BUY	$56.38 - $68.08 $113,492 - $137,045	2,013 Added 2.93%	70,700 $0
Q1 2018 May 14, 2018	BUY	$56.98 - $72.41 $92,877 - $118,028	1,630 Added 2.43%	68,687 $4 Million
Q4 2017 Feb 13, 2018	SELL	$53.3 - $74.56 $27,822 - $38,920	-522 Reduced 0.77%	67,057 $4.32 Million
Q3 2017 Nov 02, 2017	BUY	$43.46 - $52.49 $2.94 Million - $3.55 Million	67,579	67,579 $3.55 Million

Others Institutions Holding ANIP

# of Institutions

213

Shares Held

18.7M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.05B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Ani Pharmaceuticals Inc Transaction History